Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity

被引:210
作者
Chakaroun, Rima [1 ]
Raschpichler, Matthias [1 ]
Kloeting, Nora [2 ]
Oberbach, Andreas [3 ]
Flehmig, Gesine [1 ]
Kern, Matthias [1 ]
Schoen, Michael R. [4 ]
Shang, Edward [5 ]
Lohmann, Tobias [6 ]
Dressler, Miriam [6 ]
Fasshauer, Mathias [1 ]
Stumvoll, Michael [1 ]
Bluether, Matthias [1 ]
机构
[1] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany
[2] Univ Leipzig, IFB Obes Dis, Jr Res Grp Anim Models, D-04103 Leipzig, Germany
[3] Univ Leipzig, Dept Pediat Surg, D-04103 Leipzig, Germany
[4] Stadt Klinikum Karlsruhe, Clin Visceral Surg, D-76133 Karlsruhe, Germany
[5] Univ Leipzig, Dept Surg, D-04103 Leipzig, Germany
[6] Municipal Clin Dresden Neustadt, D-01129 Dresden, Germany
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2012年 / 61卷 / 05期
关键词
TYPE-2; DIABETES-MELLITUS; METABOLIC SYNDROME; INSULIN-RESISTANCE; BARIATRIC SURGERY; INFLAMMATION; ATHEROSCLEROSIS; ADIPOKINE; MARKERS; FAT;
D O I
10.1016/j.metabol.2011.10.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chemerin is a chemoattractant adipokine that regulates adipogenesis and may induce insulin resistance. Chemerin serum concentrations are elevated in obese, insulin-resistant, and inflammatory states in vivo. Here we investigate the role of omental (OM) and subcutaneous (SC) adipose tissue chemerin and CMKLR1 messenger RNA (mRNA) expression in human obesity. In addition, we test the hypothesis that changes in chemerin serum concentrations are primarily associated with reduced body fat mass in the context of 3 weight loss intervention studies. Chemerin serum concentration was measured in 740 individuals in a cross-sectional (n = 629) study including a subgroup (n = 161) for which OM and SC chemerin mRNA expression has been analyzed as well as in 3 interventions including 12 weeks of exercise (n = 60), 6 months of calorie-restricted diet (n = 19) studies, and 12 months after bariatric surgery (n = 32). Chemerin mRNA is significantly higher expressed in adipose tissue of patients with type 2 diabetes mellitus and correlates with circulating chemerin, body mass index (BMI), percentage body fat, C-reactive protein, homeostasis model assessment of insulin resistance, and glucose infusion rate in euglycemic-hyperinsulinemic clamps. CMKLR1 mRNA expression was not significantly different between the 2 fat depots. Obesity surgery-induced weight loss causes a significant reduction on both OM and SC chemerin expression. All interventions led to significantly reduced chemerin serum concentrations. Decreased chemerin serum concentrations significantly correlate with improved glucose infusion rate and reduced C-reactive protein levels independently of changes in BMI. Insulin resistance and inflammation are BMI-independent predictors of elevated chemerin serum concentrations. Reduced chemerin expression and serum concentration may contribute to improved insulin sensitivity and subclinical inflammation beyond significant weight loss. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:706 / 714
页数:9
相关论文
共 26 条
[1]   The genetic design of signaling cascades to record receptor activation [J].
Barnea, Gilad ;
Strapps, Walter ;
Herrada, Gilles ;
Berman, Yemiliya ;
Ong, Jane ;
Kloss, Brian ;
Axel, Richard ;
Lee, Kevin J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (01) :64-69
[2]   Expression of Human Chemerin Induces Insulin Resistance in the Skeletal Muscle but Does Not Affect Weight, Lipid Levels, and Atherosclerosis in LDL Receptor Knockout Mice on High-Fat Diet [J].
Becker, Melanie ;
Rabe, Katja ;
Lebherz, Corinna ;
Zugwurst, Julia ;
Goeke, Burkhard ;
Parhofer, Klaus G. ;
Lehrke, Michael ;
Broedl, Uli C. .
DIABETES, 2010, 59 (11) :2898-2903
[3]   Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training [J].
Blueher, Matthias ;
Williams, Catherine J. ;
Kloeting, Nora ;
Hsi, Alex ;
Ruschke, Karen ;
Oberbach, Andreas ;
Fasshauer, Mathias ;
Berndt, Janin ;
Schoen, Michael R. ;
Wolk, Alicja ;
Stumvoll, Michael ;
Mantzoros, Christos S. .
DIABETES CARE, 2007, 30 (12) :3110-3115
[4]   Adipose Tissue Dysfunction in Obesity [J].
Bluehre, M. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2009, 117 (06) :241-250
[5]   Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes [J].
Blüher, M ;
Unger, R ;
Rassoul, F ;
Richter, V ;
Paschke, R .
DIABETOLOGIA, 2002, 45 (02) :210-216
[6]   Chemerin is a novel adipokine associated with obesity and metabolic syndrome [J].
Bozaoglu, Kiymet ;
Bolton, Kristy ;
McMillan, Janine ;
Zimmet, Paul ;
Jowett, Jeremy ;
Collier, Greg ;
Walder, Ken ;
Segal, David .
ENDOCRINOLOGY, 2007, 148 (10) :4687-4694
[7]   Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population [J].
Bozaoglu, Kiymet ;
Segal, David ;
Shields, Katherine A. ;
Cummings, Nik ;
Curran, Joanne E. ;
Comuzzie, Anthony G. ;
Mahaney, Michael C. ;
Rainwater, David L. ;
VandeBerg, John L. ;
MacCluer, Jean W. ;
Collier, Greg ;
Blangero, John ;
Walder, Ken ;
Jowett, Jeremy B. M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (08) :3085-3088
[8]   Synthetic chemerin-derived peptides suppress inflammation through ChemR23 [J].
Cash, Jenna L. ;
Hart, Rosie ;
Russ, Andreas ;
Dixon, John P. C. ;
Colledge, William H. ;
Doran, Joanne ;
Hendrick, Alan G. ;
Carlton, Mark B. L. ;
Greaves, David R. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (04) :767-775
[9]   Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease [J].
El-Mesallamy, H. O. ;
El-Derany, M. O. ;
Hamdy, N. M. .
DIABETIC MEDICINE, 2011, 28 (10) :1194-1200
[10]   Chemerin Exacerbates Glucose Intolerance in Mouse Models of Obesity and Diabetes [J].
Ernst, Matthew C. ;
Issa, Mark ;
Goralski, Kerry B. ;
Sinal, Christopher J. .
ENDOCRINOLOGY, 2010, 151 (05) :1998-2007